Yu et al., 2016 - Google Patents
Potential approaches to the treatment of Ewing's sarcomaYu et al., 2016
View HTML- Document ID
- 8006308048473222675
- Author
- Yu H
- Ge Y
- Guo L
- Huang L
- Publication year
- Publication venue
- Oncotarget
External Links
Snippet
Ewing's sarcoma (ES) is a highly aggressive and metastatic tumor in children and young adults caused by a chromosomal fusion between the Ewing sarcoma breakpoint region 1 (EWSR1) gene and the transcription factor FLI1 gene. ES is managed with standard …
- 208000006168 Ewing Sarcoma 0 title abstract description 261
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Potential approaches to the treatment of Ewing's sarcoma | |
| Morales et al. | Role of immunotherapy in Ewing sarcoma | |
| Heymann et al. | Bone sarcomas in the immunotherapy era | |
| Wang et al. | B7‐H3‐mediated tumor immunology: friend or foe? | |
| de la Rocha et al. | Role of SOX family of transcription factors in central nervous system tumors | |
| Conyers et al. | Liposarcoma: molecular genetics and therapeutics | |
| Schatton et al. | Identification and targeting of cancer stem cells | |
| Ahmed et al. | Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies | |
| Semenova et al. | Origins, genetic landscape, and emerging therapies of small cell lung cancer | |
| Neuzillet et al. | Targeting the Ras–ERK pathway in pancreatic adenocarcinoma | |
| Chan et al. | Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy | |
| Guo et al. | Chimeric antigen receptor‐modified T cells for solid tumors: challenges and prospects | |
| Del Vecchio et al. | Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas | |
| ES2489475T3 (en) | MET inhibitors to enhance the effectiveness of radiotherapy | |
| JP2024120909A (en) | Use of flt3 car-t cells and flt3 inhibitors to treat acute myeloid leukemia | |
| Lucifero et al. | Innovative therapies for malignant brain tumors: the road to a tailored cure | |
| Ahmad | Introduction to cancer metastasis | |
| Mavroudi et al. | Stem cells’ guided gene therapy of cancer: New frontier in personalized and targeted therapy | |
| Tucker et al. | Revisiting the tenascins: exploitable as cancer targets? | |
| Singh et al. | Gene and cell therapy for pancreatic cancer | |
| Lim et al. | Lateral inhibition of Notch signaling in neoplastic cells | |
| Huang et al. | Current therapeutic approaches in metastatic and recurrent ewing sarcoma | |
| Jiang et al. | Molecular mechanisms and countermeasures of immunotherapy resistance in malignant tumor | |
| JP2025094220A (en) | Cancer vaccine compositions and methods of using same for preventing and/or treating cancer - Patents.com | |
| Graham et al. | Nk cells in the lymph nodes and their role in anti-tumour immunity |